Correlation Between Revolution Medicines, and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines, and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines, and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines, Warrant and Inhibrx, you can compare the effects of market volatilities on Revolution Medicines, and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines, with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines, and Inhibrx.
Diversification Opportunities for Revolution Medicines, and Inhibrx
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Revolution and Inhibrx is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines, Warrant and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Revolution Medicines, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines, Warrant are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Revolution Medicines, i.e., Revolution Medicines, and Inhibrx go up and down completely randomly.
Pair Corralation between Revolution Medicines, and Inhibrx
Assuming the 90 days horizon Revolution Medicines, Warrant is expected to generate 5.93 times more return on investment than Inhibrx. However, Revolution Medicines, is 5.93 times more volatile than Inhibrx. It trades about 0.04 of its potential returns per unit of risk. Inhibrx is currently generating about -0.17 per unit of risk. If you would invest 16.00 in Revolution Medicines, Warrant on October 26, 2024 and sell it today you would lose (4.00) from holding Revolution Medicines, Warrant or give up 25.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Revolution Medicines, Warrant vs. Inhibrx
Performance |
Timeline |
Revolution Medicines, |
Inhibrx |
Revolution Medicines, and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revolution Medicines, and Inhibrx
The main advantage of trading using opposite Revolution Medicines, and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines, position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Revolution Medicines, vs. Cementos Pacasmayo SAA | Revolution Medicines, vs. Acm Research | Revolution Medicines, vs. BRP Inc | Revolution Medicines, vs. Valmont Industries |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |